Information On Expected Conclusion Of Commissioning Agreement For The Drug Fruzaqla (Fruquintinib)

Amgros I S Denmark has Released a tender for Information On Expected Conclusion Of Commissioning Agreement For The Drug Fruzaqla (Fruquintinib) in Pharmaceuticals. The tender was released on Jul 12, 2024.

Country - Denmark

Summary - Information On Expected Conclusion Of Commissioning Agreement For The Drug Fruzaqla (Fruquintinib)

Deadline - Jul 11, 2025

MT reference number - 18734112

Product classification - Pharmaceutical products

Organization Details:

  Address - Denmark

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 18734112

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This advance notification is an information about Amgros' expected conclusion of a commissioning agreement for a medicinal product covered by section 3.1.Amgros will enter into start-up agreements with all interested parties, and Amgros therefore encourages everyone who will potentially enter into Amgros' start-up agreements for the medicine below to express interest by sending relevant information including price to udbud@amgros.dk. At a later date, Amgros expects to tender the covered medicinal product as a tendered framework agreement to public tender, and the expectation is that the tender will be published within the next 6 months, but this will however depend on several fa

Mt Ref Id - 18734112

Deadline - Jul 11, 2025

Share

Similar Tenders :